phase 3 study - Robuta Search

https://www.dukehealth.org/clinical-trials/directory/pro00115048 Randomized Phase 3 study of Peri-op... | Clinical Trials at Duke phase 3 study clinical trials randomized https://www.takeda.com/newsroom/shire-news-releases/2013/shire-regenerative-medicine-initiates-phase-3-study-of-abh001-for-patients-with-epidermolysis-bullosa/ Shire Regenerative Medicine Initiates Phase 3 Study Of ABH001 For Patients With Epidermolysis... Shire Regenerative Medicine Initiates Phase 3 Study Of ABH001 For Patients With Epidermolysis Bullosa phase 3 study https://www.merck.com/news/merck-and-ridgeback-announce-publication-of-phase-3-study-of-molnupiravir-an-investigational-oral-antiviral-covid-19-treatment-in-the-new-england-journal-of-medicine/ Merck and Ridgeback Announce Publication of Phase 3 Study of Molnupiravir, an Investigational Oral... Apr 17, 2026 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced the New England Journal of Medicine has... phase 3 study https://www.amgen.com/newsroom/press-releases/2012/08/amgen-announces-termination-of-ganitumab-phase-3-study-for-futility-in-metastatic-pancreatic-cancer Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic... phase 3 study https://www.finanznachrichten.de/nachrichten-2026-04/68113338-immunovant-inc-immunovant-announces-phase-3-study-results-for-batoclimab-in-thyroid-eye-disease-ted-399.htm Immunovant Inc.: Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease... Phase 3 studies of batoclimab in thyroid eye disease (TED) each failed to meet their primary endpoint; safety results were consistent with previous... phase 3 study https://www.takeda.com/newsroom/newsreleases/2023/takeda-presents-positive-results-from-phase-3-study-of-vedolizumab/ Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal... Takeda today announced late-breaking data from the Phase 3 GRAPHITE study presented at the 2023 Tandem Meetings, demonstrating vedolizumab achieved a... phase 3 study https://www.mskcc.org/cancer-care/clinical-trials/24-236 A Phase 3 Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed in... Full Title A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination with Carboplatin plus Pemetrexed Versus... phase 3 study https://www.biospace.com/press-releases/lib-therapeutics-announces-publication-of-phase-3-study-of-lerodalcibep-in-homozygous-familial-hypercholesterolemia-hofh-in-lancet-diabetes-endocrinology LIB Therapeutics Announces Publication of Phase 3 Study of Lerodalcibep in Homozygous Familial... phase 3 study https://www.southampton.ac.uk/research/projects/randomized-assessor-masked-active-controlled-phase-3-study-to-evaluate-efficacy Randomized, Assessor-Masked , Active-Controlled, Phase 3 Study to Evaluate Efficacy, Safety and... Randomized, Assessor-Masked , Active-Controlled, Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of 0.08% Polyhexamethylene Biguanide (PHMB)... phase 3 study https://investingnews.com/moderna-announces-initiation-of-phase-3-study-of-investigational-mrna-pandemic-influenza-vaccine-candidate/ Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine... Apr 22, 2026 - Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat... phase 3 study https://www.biospace.com/biocryst-pharmaceuticals-asks-for-extension-on-phase-3-study Biocryst Pharmaceuticals Asks for Extension on Phase 3 Study - BioSpace phase 3 study biocryst pharmaceuticals for extension asks https://investingnews.com/tag/phase-3-study phase 3 study | INN phase 3 study inn https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT01844505&r=1 Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously... Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067) phase 3 study https://www.mskcc.org/cancer-care/clinical-trials/25-103 A Phase 3 Study Comparing Three Combination Treatments for Newly Diagnosed Multiple Myeloma |... Full Title A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination with... phase 3 study https://www.mskcc.org/cancer-care/clinical-trials/25-318 A Phase 3 Study of Induction Therapy Added to Chemoradiation and Pembrolizumab Maintenance Therapy... Full Title A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both... phase 3 study https://finviz.com/news/341989/immunovant-announces-phase-3-study-results-for-batoclimab-in-thyroid-eye-disease-ted Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED) Stock screener for investors and traders, financial visualizations. phase 3 study https://www.bcm.edu/healthcare/clinical-trials/h-54744 Phase 3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION) | BCM The purpose of this study is to find out how safe and effective the new drug, AMX0035, is for the treatment of PSP and to determine if AMX0035 can slow... phase 3 study https://www.mayo.edu/research/clinical-trials/cls-20145297 Phase 3 Study to Treat Patients with Soft Tissue Sarcomas - Mayo Clinic Learn more about services at Mayo Clinic. phase 3 study soft tissue sarcomas https://www.news-medical.net/news/20130603/Amgen-reports-encouraging-results-from-talimogene-laherparepvec-phase-3-study-in-patients-with-metastatic-melanoma.aspx Amgen reports encouraging results from talimogene laherparepvec phase 3 study in patients with... Jun 20, 2019 - Amgen today announced detailed results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV... phase 3 study https://www.dukehealth.org/clinical-trials/directory/pro00116787 Phase 3 Study of MK-3543... | Clinical Trials at Duke You can choose to join this study when you finish your current/previous trial of the study drug. If you are interested in joining,... | View the details of... phase 3 study clinical trials mk 3543 duke https://www.finanznachrichten.de/nachrichten-2026-04/68260957-moderna-inc-moderna-announces-initiation-of-phase-3-study-of-investigational-mrna-pandemic-influenza-vaccine-candidate-200.htm Moderna, Inc.: Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic... Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat... phase 3 study moderna inc announces initiation https://www.businesswire.com/news/home/20201123005602/en/Pfizer-Doses-First-Participant-in-Phase-3-Study-Evaluating-anti-TFPI-Investigational-Therapy-Marstacimab-for-People-With-Severe-Hemophilia-A-and-B-With-or-Without-Inhibitors Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy,... Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 BASIS study of marstacimab (PF-06741086), an anti-tissue fac... phase 3 study https://www.techtarget.com/pharmalifesciences/news/366608020/Pfizer-Opens-First-US-Phase-3-Study-Evaluating-Gene-Therapy Pfizer Opens First US Phase 3 Study Evaluating Gene Therapy | TechTarget Pfizer will open the first US sites in the Phase 3 study evaluating its investigational mini-dystrophin gene therapy, fordadistrogene movaparvovec, in... phase 3 study gene therapy pfizer opens first https://www.gsk.com/en-gb/media/press-releases/gsk-starts-phase-3-study-of-rsv-maternal-candidate-vaccine/ GSK starts phase 3 study of RSV maternal candidate vaccine | GSK RSV is a leading cause of respiratory infections such as bronchiolitis and viral pneumonia in infants. phase 3 study gsk starts rsv maternal https://www.businesswire.com/news/home/20230721916957/en/Gilead-To-Discontinue-Phase-3-ENHANCE-Study-of-Magrolimab-Plus-Azacitidine-in-Higher-Risk-MDS Gilead To Discontinue Phase 3 ENHANCE Study of Magrolimab Plus Azacitidine in Higher-Risk MDS Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Phase 3 ENHANCE study in higher-risk myelodysplastic syndromes (MDS) has been discontinued due ... https://www.prnewswire.com/news-releases/amgen-and-kyowa-kirin-provide-top-line-results-from-rocatinlimab-phase-3-ignite-study-in-adults-with-moderate-to-severe-atopic-dermatitis-302396130.html AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS... /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) today announced new results from the ongoing ROCKET Phase 3 clinical... https://www.globenewswire.com/news-release/2025/05/28/3089331/0/en/Spero-Therapeutics-and-GSK-Announce-PIVOT-PO-Phase-3-Study-for-Tebipenem-HBr-Stopped-Early-for-Efficacy-Following-Review-by-Independent-Data-Monitoring-Committee.html Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study If approved, tebipenem HBr could be the first oral carbapenem antibiotic for US patients with complicated urinary tract infections (cUTIs) An estimated 2.9... phase 3 spero therapeutics gsk announce https://www.rush.edu/clinical-trials/pediatric-vitiligo-study-ruxolitinib-cream-phase-3-trial Pediatric Vitiligo Study: Ruxolitinib Cream Phase 3 Trial | Rush This Phase 3 study is testing a cream called ruxolitinib in children ages 2 to under 12 who have nonsegmental vitiligo, a skin condition that causes white... phase 3 trial pediatric vitiligo study ruxolitinib